These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 430475)
1. Inhibition of uptake of catecholamines by benzylamine derivatives. Kammerer RC; Amiri B; Cho AK J Med Chem; 1979 Apr; 22(4):352-5. PubMed ID: 430475 [TBL] [Abstract][Full Text] [Related]
2. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine. Horn AS; Snyder SH J Pharmacol Exp Ther; 1972 Mar; 180(3):523-30. PubMed ID: 5012779 [No Abstract] [Full Text] [Related]
3. Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates. Horn AS Br J Pharmacol; 1973 Feb; 47(2):332-8. PubMed ID: 4722047 [TBL] [Abstract][Full Text] [Related]
4. Release of biogenic amines from isolated nerve endings. Raiteri M; Bertollini A; del Carmine R; Levi G Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741 [No Abstract] [Full Text] [Related]
5. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. Harris JE; Baldessarini RJ Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376 [No Abstract] [Full Text] [Related]
6. Effects of apomorphine in vitro on the uptake and release of catecholamines in crude synaptosomal preparations of rat striatum and hypothalamus. Ferris RM; Tang FL; Russell AV Biochem Pharmacol; 1975 Aug; 24(16):1523-7. PubMed ID: 1191310 [No Abstract] [Full Text] [Related]
7. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives. Tessel RE; Rutledge CO J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of synaptosomal uptake of norepinephrine and dopamine by conformationally restricted sympathomimetic amines. Komiskey HL; Hsu FL; Bossart FJ; Fowble JW; Miller DD; Patil PN Eur J Pharmacol; 1978 Nov; 52(1):37-45. PubMed ID: 720387 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study. Howard-Butcher S; Blaha CD; Lane RF J Pharmacol Exp Ther; 1985 Apr; 233(1):58-63. PubMed ID: 3981462 [TBL] [Abstract][Full Text] [Related]
10. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. Heikkila RE; Orlansky H; Mytilineou C; Cohen G J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755 [TBL] [Abstract][Full Text] [Related]
11. The effects of xylamine, a nitrogen mustard on [3H]norepinephrine accumulation in rabbit aorta. Cho AK; Ransom RW; Fischer JB; Kammerer RC J Pharmacol Exp Ther; 1980 Aug; 214(2):324-7. PubMed ID: 7391980 [TBL] [Abstract][Full Text] [Related]
12. The accumulation of p-hydroxyamphetamine by brain homogenates and its role in the release of catecholamines. Cho AK; Fischer JF; Schaeffer JC Biochem Pharmacol; 1977 Aug; 26(15):1367-72. PubMed ID: 901551 [No Abstract] [Full Text] [Related]
13. Stereoselectivity of catecholamine uptake by brain synaptosomes: studies with ephedrine, methylphenidate and phenyl-2-piperidyl carbinol. Hendley ED; Snyder SH; Fauley JJ; LaPidus JB J Pharmacol Exp Ther; 1972 Oct; 183(1):103-16. PubMed ID: 5080026 [No Abstract] [Full Text] [Related]
14. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. Ferris RM; Tang FL; Maxwell RA J Pharmacol Exp Ther; 1972 Jun; 181(3):407-16. PubMed ID: 5033010 [No Abstract] [Full Text] [Related]
15. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters. Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783 [TBL] [Abstract][Full Text] [Related]
17. N,N-Dimethyl-alpha-[2-(p-tolyloxy)ethyl]benzylamine hydrochloride (LY125180). Effects on serotonin uptake and serotonin synthesis in rat brain in vitro and in vivo. Wong DT; Bymaster FP; Chen S; Molloy BB Biochem Pharmacol; 1980 Mar; 29(6):935-41. PubMed ID: 6966930 [No Abstract] [Full Text] [Related]
18. Preferential uptake of norepinephrine into dopaminergic terminals of a synaptosomal preparation from rat cerebral cortex. Michel M; Hiemke C; Ghraf R Brain Res; 1984 May; 301(1):149-52. PubMed ID: 6329439 [TBL] [Abstract][Full Text] [Related]
19. Release of endogenous catecholamines from isolated rat brain tissue by fenfluramine and N-ethylamphetamine--effects of pargyline. Tessel RE; Burgess SK; Rutledge CO Biochem Pharmacol; 1978; 27(12):1631-6. PubMed ID: 697904 [No Abstract] [Full Text] [Related]
20. Effects of amphetamines on the metabolism of catecholamines in the rat brain. Baldessarini RJ; Harris JE J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777 [No Abstract] [Full Text] [Related] [Next] [New Search]